ATHL1 抗体 (C-Term)
Cited in 2+ publications. This 兔 多克隆 anti-ATHL1 antibody (Clone RB26022) specifically detects ATHL1 in WB, FACS 和 IHC (p). The antibody is reactive with 人 samples.
(2 references)
产品编号 ABIN1881084
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for ATHL1 抗体 (C-Term) (ABIN1881084)
抗原
ATHL1
(ATH1, Acid Trehalase-Like 1 (ATHL1))
适用
人
宿主
兔
克隆类型
多克隆
标记
This ATHL1 antibody is un-conjugated
应用范围
Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
克隆位点
RB26022
-
-
抗原表位
- AA 688-716, C-Term
-
纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
免疫原
- This ATHL1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 688-716 amino acids from the C-terminal region of human ATHL1.
-
亚型
- Ig Fraction
-
-
anti-ATH1, Acid Trehalase-Like 1 (ATHL1) antibody
ATHL1 适用: 人 WB, FACS, IHC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
有效期
- 6 months
-
-
-
: "Glycosylation-related gene expression is linked to differentiation status in glioblastomas undifferentiated cells." in: Cancer letters, Vol. 312, Issue 1, pp. 24-32, (2011) (PubMed).
: "Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney aging." in: PLoS genetics, Vol. 5, Issue 10, pp. e1000685, (2009) (PubMed).
-
: "Glycosylation-related gene expression is linked to differentiation status in glioblastomas undifferentiated cells." in: Cancer letters, Vol. 312, Issue 1, pp. 24-32, (2011) (PubMed).
-
-
You are here:
